Natural OTCs prepare for lift off
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Increasing demand for more natural products is opening up an enticing opportunity for consumer healthcare players.Tom Gallen explores the tools firms can use to make their brands stand out in this growing market.
You may also be interested in...
Robitussin Gets Natural With Honey, Ivy Leaf, Eucalyptus Supplements For Cough Relief
GSK launches Robitussin Naturals drug-free cough and cold remedies in the first naturals offering under the top-selling OTC drug brand. The line includes liquids and gummies for adults and children formulated with honey, ivy leaf and eucalyptus.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.